Conor Kilroy is Secretary & SVP at IRONWOOD PHARMACEUTICALS INC (IRWD). They have made 3 open-market trades across 1 company since 2020, most recently 2026-07-01.
CIK 0001808510
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AURA | 232,693 | $1.4M |
| IRWD | 122,336 | $427K |
| Total | $1.8M |
Shares reported on the most recent Form 4, priced at the 2026-07-01 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AURA | SELL | 2026-04-16 | 2026-04-16 | $7.02 | $82K | -3.4% | +4.3% | -2.2% |
| AURA | SELL | 2026-02-17 | 2026-02-17 | $5.05 | $61K | +12.6% | +25.8% | +43.0% |
| AURA | SELL | 2025-04-16 | 2025-04-16 | $5.49 | $39K | +3.5% | +10.8% | +22.2% |
| IRWD | SELL · 10b5-1 | 2021-02-26 | 2021-03-02 | $9.11 | $64K | +11.5% | +7.2% | +13.9% |
| IRWD | SELL · 10b5-1 | 2020-11-09 | 2020-11-10 | $10.92 | $9K | +2.2% | +5.1% | -7.5% |
| IRWD | SELL · 10b5-1 | 2020-05-11 | 2020-05-13 | $10.35 | $7K | +12.5% | -12.1% | -4.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.